SCHEMBL8005151

SCHEMBL8005151

O=C1NCC=NN1c1cc(Cl)c(Cc2ccc(C(O)c3ccc[nH]3)cc2)c(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7998698 0.87 CYP17A1 (0.35)
SCHEMBL7990341 0.86 ALDH1A1 (0.33)
SCHEMBL8002255 0.84 EGFR (0.32)
SCHEMBL7999093 0.83
SCHEMBL8001913 0.83 TSHR (0.34)
SCHEMBL8002371 0.83 SMN1; SMN2 (0.38)
SCHEMBL7998640 0.82 ALDH1A1 (0.30)
SCHEMBL8004871 0.82 MAPT (0.37)
SCHEMBL8002032 0.81 LMNA (0.43)
SCHEMBL8005167 0.81 PRMT5 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294536-B1 CONTROL OF PROTOZOA AND REDUCTION IN THE INCIDENCE OF ASSOCIATED DISEASES AND DEATH AND CONSEQUENT IMPROVEMENT IN RETARDED GROWTH AND GENERAL CONDITION AND PREVENTING DECREASE GROWTH AND GENERAL CONDITION TAKEDA SCHERING-PLOUGH ANIMAL HEALTH K.K. (JP) 2001-09-25 US disclosed